Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.3K Hold
55
﹤0.01% 833
2025
Q4
$13.2K Hold
55
﹤0.01% 811
2025
Q3
$14.9K Hold
55
﹤0.01% 780
2025
Q2
$14.2K Hold
55
﹤0.01% 767
2025
Q1
$12.3K Hold
55
﹤0.01% 770
2024
Q4
$12.6K Hold
55
﹤0.01% 766
2024
Q3
$13.4K Hold
55
﹤0.01% 724
2024
Q2
$10.5K Hold
55
﹤0.01% 761
2024
Q1
$10.9K Hold
55
﹤0.01% 735
2023
Q4
$9.46K Hold
55
﹤0.01% 752
2023
Q3
$8.13K Sell
55
-16
-23% -$2.89K ﹤0.01% 776
2023
Q2
$15.5K Buy
71
+16
+29% +$3.57K 0.01% 634
2023
Q1
$12K Hold
55
﹤0.01% 637
2022
Q4
$12K Hold
55
0.01% 584
2022
Q3
$12K Hold
55
0.01% 595
2022
Q2
$12K Hold
55
0.01% 593
2022
Q1
$13K Hold
55
0.01% 572
2021
Q4
$14K Hold
55
0.01% 540
2021
Q3
$15K Hold
55
0.01% 513
2021
Q2
$15K Buy
+55
New +$11.6K 0.01% 510

Other funds holding RMD

Key Financial Inc's RMD Position: Q1 2026 in Review

Key Financial Inc held its ResMed (RMD) position steady in Q1 2026 at 55 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #833.

Key Financial Inc first reported a position in RMD in Q2 2021 and has held it in 20 quarters since. The position peaked at $15.5K in Q2 2023. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Key Financial Inc held 55 shares of ResMed worth $12.3K as of Q1 2026.
  • Key Financial Inc left its ResMed share count unchanged in Q1 2026.
  • ResMed made up ﹤0.01% of Key Financial Inc's portfolio in Q1 2026, its #833 holding.
  • Key Financial Inc first reported a position in ResMed in Q2 2021 and has held it in 20 quarters since.
  • Key Financial Inc's ResMed position peaked at $15.5K in Q2 2023.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Key Financial Inc's 13F filing for Q1 2026, filed 24 Apr 2026.